Cohort SURVI: Observational Study of Intestinal Ischemia and Vascular Diseases

What this Trial Is About

Researchers are investigating intestinal ischemia and related vascular diseases through a specialized intensive care unit called SURVI, established within the Paris-Nord Val de Seine University Hospital Group with support from AP-HP. This unit focuses on managing acute and chronic mesenteric ischemias and intestinal vascular diseases without ischemia. These conditions involve serious blood flow problems in the digestive system, and without treatment, acute mesenteric ischemia can be fatal. The study aims to better understand the prevalence, risks, and outcomes of these rare and varied vascular diseases over time. This research is an observational study that follows a group of patients with intestinal vascular ischemia (IMVI) and other intestinal vascular diseases without ischemia (IIVD). Patients included have conditions such as acute or chronic mesenteric ischemia or other arterial or venous gastrointestinal vascular diseases. The study collects data to track the natural history of these diseases, as current knowledge about their progression and outcomes is limited. No experimental treatments are administered; instead, patient health and disease progression are monitored over the years. Participants in this study will be followed longitudinally with assessments focused on mortality rates at one and five years, disease prevalence, risk factors for complications like intestinal resection, and rates of vascular restenosis or ischemic events. The study also examines the impact of these diseases on outcomes such as short intestinal syndrome and dependence on parenteral nutrition after surgery. Data collection includes clinical evaluations and medical records over an extended period, allowing researchers to better understand disease patterns and factors affecting patient survival and quality of life.

Cohort SURVI : Intestinal Ischemia and Vascular Diseases